<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04980924</url>
  </required_header>
  <id_info>
    <org_study_id>21cardio01</org_study_id>
    <nct_id>NCT04980924</nct_id>
  </id_info>
  <brief_title>Epidemiology and Clinical Course of Pulmonary Embolism During and After Hospitalisation</brief_title>
  <acronym>REMATEV</acronym>
  <official_title>Pulmonary Embolism Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This survey will allow to identify PE prognostic, but also long-term complications, i.e.&#xD;
      recurrence rate, on-treatment bleedings, deep-vein thrombosis sequella, pulmonary&#xD;
      hypertension rate, and chronic pulmonary disease rate without PH. This database should help&#xD;
      us identify risk-factors for each event.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 1992</start_date>
  <completion_date type="Anticipated">December 31, 2030</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2030</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Reccurence</measure>
    <time_frame>10 years</time_frame>
    <description>number of patient with Documented symptomatic pulmonary embolism reccurence</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pulmonary hypertension</measure>
    <time_frame>10 years</time_frame>
    <description>number of patients with Confirmed pulmonary hypertension after pulmonary embolism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic pulmonary disease without hypertension</measure>
    <time_frame>10 years</time_frame>
    <description>number of patients with dyspnea but without pulmonary hypertension, Documented non-reperfused pulmonary areas</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">2500</enrollment>
  <condition>Pulmonary Embolism</condition>
  <arm_group>
    <arm_group_label>Pulmonary Embolism without reccurence or complication</arm_group_label>
    <description>Pulmonary Embolism without reccurence or complication</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pulmonary Embolism with reccurence or complication</arm_group_label>
    <description>Pulmonary Embolism with reccurence or complication, in particular occurrence of pulmonary hypertension.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention</intervention_name>
    <description>no intervention</description>
    <arm_group_label>Pulmonary Embolism with reccurence or complication</arm_group_label>
    <arm_group_label>Pulmonary Embolism without reccurence or complication</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All pulmonary embolisms hospitalised in our department&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All pulmonary embolisms hospitalised in Nice hospital.&#xD;
&#xD;
          -  acceptation to enter in the cohorte survey&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>110 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>emile Ferrari, PUPH</last_name>
    <phone>33492037735</phone>
    <email>ferrari.e@chu-nice.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amina Zamii-Smondel</last_name>
    <phone>33492037746</phone>
    <email>zamiti-smondel.a@chu-nice.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nice University Hospital</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>emile Ferrari, PUPH</last_name>
      <phone>33492037735</phone>
      <email>ferrari.e@chu-nice.fr</email>
    </contact>
    <contact_backup>
      <last_name>amina Zamiti-Smondel</last_name>
      <phone>33492037746</phone>
      <email>zamiti-smondel.a@chu-nice.fr</email>
    </contact_backup>
    <investigator>
      <last_name>emile Ferrari, puph</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 21, 2021</study_first_submitted>
  <study_first_submitted_qc>July 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 28, 2021</study_first_posted>
  <last_update_submitted>July 28, 2021</last_update_submitted>
  <last_update_submitted_qc>July 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Embolism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

